Cole Jeffrey Scott 4
4 · Cadrenal Therapeutics, Inc. · Filed Jan 24, 2025
Insider Transaction Report
Form 4
Cole Jeffrey Scott
Chief Operating Officer
Transactions
- Award
Stock Options
2025-01-23+25,000→ 25,000 totalExercise: $19.79From: 2026-02-01Exp: 2035-01-22→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]Consists of options to purchase 25,000 shares of common stock, which shall vest 1/4 on February 1, 2026 and thereafter pro rata on a monthly basis over three years, subject to the Reporting Person's continued service to the Issuer through each vesting date, having an exercise price equal to the fair market value of the Issuer's common stock on the effective date of the grant.